SCHEMBL7974048

SCHEMBL7974048

O=c1nc(-c2cccnc2)[nH]c2ncn(CCCc3ccccc3)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 4/20 0.53
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.46
TSHR P16473 2/20 0.43
HPGD P15428 1/20 0.41
ADRA2C P18825 1/20 0.39
CYP2E1 P05181 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
DHPS P49366 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ASAH1 Q13510 1/20 0.38
CLK1 P49759 1/20 0.38
DYRK1A Q13627 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986330 0.94 CNOT7 (0.51) CNOT7TSHRHPGDADRA2CCYP2E1
SCHEMBL7984244 0.90 CNOT7 (0.60) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7991656 0.89 CNOT7 (0.55) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7974289 0.87 CNOT7 (0.53) CNOT7KDM4EPOLBHPGDCYP2E1
SCHEMBL7974041 0.84 KDM4E (0.51) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7974620 0.84 CNOT7 (0.58) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7984493 0.83 CNOT7 (0.54) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7985605 0.83 CNOT7 (0.54) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7974293 0.83 CNOT7 (0.52) CNOT7KDM4ELMNAPOLBMAPK1
SCHEMBL7987629 0.83 CNOT7 (0.52) CNOT7KDM4ELMNAPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed